Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 7/2013

01-07-2013 | Brief Report

HCV infection among cocaine users in the state of Pará, Brazilian Amazon

Authors: Aldemir B. Oliveira-Filho, Leila Sawada, Laine C. Pinto, Daiane Locks, Santana L. Bahia, I. Brasil-Costa, José Alexandre R. Lemos

Published in: Archives of Virology | Issue 7/2013

Login to get access

Abstract

In this study, the prevalence, genotype frequency, and risk factors for HCV infection in 384 cocaine users were determined. One hundred twenty-four (32.3 %) cocaine users had anti-HCV antibodies and 120 (31.3 %) had HCV-RNA. Genotyping results indicated the predominance of genotypes 1 (73.3 %) and 3 (26.7 %). Multivariate analysis showed an association of HCV infection with tattoos, shared use of paraphernalia, daily cocaine use, and a long history of cocaine use. The epidemiological aspects of HCV infection among cocaine users presented here should serve as an incentive for the establishment of a program of hepatitis C prevention and control by the local public-health authorities in the Amazon.
Literature
1.
Aaron S, McMahon JM, Milano D et al (2008) Intranasal transmission of hepatitis C virus: virological and clinical evidence. Clin Infect Dis 47:931–934PubMedCrossRef
2.
Aceijas C, Rhodes T (2007) Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 18:352–358PubMedCrossRef
3.
Allison RD, Conry-Cantilena C, Koziol D et al (2012) A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. J Infect Dis 206:654–661PubMedCrossRef
4.
Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436–2441PubMed
5.
Amon JJ, Garfein RS, Ahdieh-Grant L et al (2008) Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004. Clin Infect Dis 46:1852–1858PubMedCrossRef
6.
Caiaffa WT, Zocratto KF, Osimani ML et al (2010) Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge? Addiction 106:143–151PubMedCrossRef
7.
Campiotto S, Pinho JR, Carrilho FJ et al (2005) Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 38:41–49PubMedCrossRef
8.
Campollo O, Roman S, Panduro A et al (2012) Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 123:269–272PubMedCrossRef
9.
Carvalho HB, Seibel SD, Burattini MN, Massad E, Reingold A (2003) Hepatitis B and C and syphilis vulnerability related infections among institutionalized disadvantaged youth in São Paulo-Brazil. J Bras Doenças Sex Transm 15:41–45
10.
Fischer B, Powis J, Firestone Cruz M (2008) Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol 20:29–32PubMedCrossRef
11.
Galperim B, Cheinquer H, Stein A et al (2004) Intranasal cocaine use does not appear to be an independent risk factor for HCV infection. Addiction 99:973–977PubMedCrossRef
12.
Gelberg L, Robertson MJ, Arangua L et al (2012) Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles. Public Health Rep 127:407–421PubMed
13.
Hermanstyne KA, Bangsberg DR, Hennessey K et al (2012) The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf) 34:330–339CrossRef
14.
15.
Lopes CL, Teles SA, Espírito-Santo MP et al (2009) Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. Rev Saude Publica 43:43–50PubMedCrossRef
16.
Macías J, Palacios RB, Claro E et al (2008) High prevalence of hepatitis C virus infection among non-injecting drug users: association with sharing the inhalation implements of crack. Liver Int 28:781–786PubMedCrossRef
17.
Martinez A, Talal AH (2008) Non-injection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int 28:757–760PubMedCrossRef
18.
Martins T, Narciso-Schiavon JL, Schiavon LL (2011) Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras 57:107–112PubMedCrossRef
19.
McMahon JM, Tortu S (2003) A potential hidden source of hepatitis C infection among non-injecting drug users. J Psychoactive Drugs 35:455–460PubMedCrossRef
20.
McMahon JM, Simm M, Milano D, Clatts M (2004) Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob. doi:10.​1186/​1476-0711-3-6 PubMed
21.
Morice Y, Cantaloube JF, Beaucourt S et al (2006) Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296–1303PubMedCrossRef
22.
Murakami J, Nagata I, Iitsuka T et al (2012) Risk factors for mother-to-child transmission of hepatitis C virus: Maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42:648–657PubMedCrossRef
23.
Novais AC, Lopes CL, Reis NR et al (2009) Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 104:892–896PubMedCrossRef
24.
Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cad Saude Publica 26:837–844PubMedCrossRef
25.
Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Prevalence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern Brazil. Mem Inst Oswaldo Cruz 105:103–106PubMedCrossRef
26.
Oliveira-Filho AB, Oliveira EH, Castro JAA, Silva LV, Vallinoto ACR, Lemos JAR (2012) Epidemiological aspects of HCV infection in HIV-infected individuals in Piauí State Northeast Brazil. Arch Virol. doi:10.​1007/​s00705-012-1435-3 PubMed
27.
Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:607–616PubMedCrossRef
28.
Sawada L, Pinheiro AC, Locks D et al (2011) Distribution of hepatitis C virus genotypes among different exposure categories in the State of Pará, Brazilian Amazon. Rev Soc Bras Med Trop 44:8–12PubMedCrossRef
29.
Scheinmann R, Hagan H, Lelutiu-Weinberger C et al (2007) Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend 89:1–12PubMedCrossRef
30.
Segurado AC, Braga P, Etzel A, Cardoso MR (2004) Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS 18:135–143PubMedCrossRef
31.
Silva MB, Andrade TM, Silva LK et al (2010) Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil. Mem Inst Oswaldo Cruz 105:299–303PubMedCrossRef
32.
Terrault NA, Dodge JL, Murphy EL et al (2012) Sexual transmission of HCV among monogamous heterosexual couples: the HCV partners study. Hepatology. doi:10.​1002/​hep.​26164 PubMed
33.
van den Berg CH, van de Laar TJ, Kok A et al (2009) Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat 16:568–577PubMedCrossRef
34.
Wang CC, Krantz E, Klarquist J et al (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 196:1474–1482PubMedCrossRef
35.
Xia X, Luo J, Bai J, Yu R (2008) Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 122:990–1003PubMedCrossRef
Metadata
Title
HCV infection among cocaine users in the state of Pará, Brazilian Amazon
Authors
Aldemir B. Oliveira-Filho
Leila Sawada
Laine C. Pinto
Daiane Locks
Santana L. Bahia
I. Brasil-Costa
José Alexandre R. Lemos
Publication date
01-07-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1627-5

Other articles of this Issue 7/2013

Archives of Virology 7/2013 Go to the issue

Rapid Communication

Genomic classification of betanodavirus by molecular phylogenetic analysis of the coat protein gene

Brief Report

Construction of an infectious cDNA clone of radish mosaic virus, a crucifer-infecting comovirus

Original Article

Genetic variability of subgroup A and B respiratory syncytial virus strains circulating in southwestern China from 2009 to 2011

Erratum

Erratum to: Genetic characterization of betanodavirus isolates from Asian seabass Lates calcarifer (Bloch) in India

Brief Report

Prevalence and molecular characterization of porcine enteric caliciviruses and first detection of porcine kobuviruses in US swine

Annotated Sequence Record

Molecular characterization of a novel monopartite begomovirus isolated from Pouzolzia zeylanica in China
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits